Pricing and pack information for Oral tablet, Oral capsule and Oral solution forms of Gabapentin Show CD3 (Schedule 3 (CD No Register Exempt Safe Custody)) Gabapentin 600mg tablets Alliance Healthcare (Distribution) Ltd Show Cautionary and advisory labels. Label . 3. Warning: This medicine may make you sleepy. The use of gabapentin for spasticity and for oscillopsia in people with multiple sclerosis is off-label. Gabapentin is a Class C controlled substance (under the Misuse of Drugs Act 1971): Careful evaluation for a history of drug abuse is required before prescribing — monitor for development of signs of abuse and dependence [ MHRA, 2019 ; NICE Motor neurone disease is a neurodegenerative condition affecting the brain and spinal cord. Degeneration of motor neurones leads to progressive muscle weakness; resulting symptoms include muscle cramps, wasting and stiffness, loss of dexterity, reduced respiratory function and cognitive dysfunction. For detailed prescribing information on gabapentin, see prescribing information section Gabapentin in the CKS topic on Neuropathic pain - drug treatment. [EMC, 2024b; BNF, 2025] Instalments and repeatable prescriptions. Prescriptions for Schedule 2 or 3 Controlled Drugs can be dispensed by instalments. An instalment prescription must have an instalment direction including both the dose and the instalment amount specified separately on the prescription, and it must also state the interval between each time the medicine can be supplied. It does not cover gabapentinoids prescribed for epilepsy, nor opioids prescribed for acute or cancer pain, or at the end of life, nor management of illicit drug dependence. This guideline includes recommendations on: See visual summaries on the recommendations for discussing starting a medicine and making a management plan and reviewing medicines. What issues should I consider before prescribing gabapentin? For prescribing information, see the section on Gabapentin in the CKS topic on Neuropathic pain - drug treatment . The content on the NICE Clinical Knowledge Summaries site (CKS) is the copyright of Clarity Informatics Limited (trading as Agilio Software Primary Care) . Analgesic Tapering Guidelines for adult patients with persistent pain patients taking strong opioids and/or gabapentinoids. Prescribing of gabapentinoids for neuropathic pain should be reviewed in line with the criteria set out in NICE4 and should be gradually discontinued if ineffective. Both Gabapentin and Prochlorperazine have effects on the CNS and can cause sedation, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in Guidance on Prescribing). In some cases, use of two or more drugs that have effects on the CNS might also increase the risk of CNS depressant effects (which could range from However, the National Institute for Health and Care Excellence (NICE) recommends gabapentin as a first-line treatment option for adults with all neuropathic pain (except trigeminal neuralgia) [NICE, 2019a]. Fast titration (usually suitable for otherwise healthy younger adults). Gabapentin is also effective for the treatment of neuropathic pain. Neuropathic pain may respond to opioid analgesics. There is evidence of efficacy for tramadol hydrochloride, morphine, and oxycodone hydrochloride; however, treatment with morphine or oxycodone hydrochloride should be initiated only under specialist supervision. Gabapentin is used for the treatment of menopausal symptoms, A but is not licensed for this indication. In adults: Gabapentin is used for oscillopsia in multiple sclerosis, E but is not licensed for this indication. For further information on contraindications, cautions, drug interactions, and adverse effects, see the electronic Medicines Compendium (eMC), or the British National Formulary (BNF). Amitriptyline Pregabalin British National Formulary (BNF) Key information on the selection, prescribing, dispensing and administration of medicines. British National Formulary for Children (BNFC) (11) NICE guidelines (11) Showing 1 to 15 of 23 results for gabapentin. See the list of drugs that interact with Gabapentin. Includes information on severity of interaction and the level of evidence for it. Public Health England's report and the government's consultation on the reclassification of gabapentin and pregabalin indicate that prescriptions of gabapentin increased from 4.9 million prescriptions in 2013 (before implementation of NICE's guideline on neuropathic pain in adults, which published in November 2013) to 7.1 million prescriptions The person should be evaluated carefully for a history of drug abuse before prescribing gabapentin or pregabalin and observed for development of signs of abuse and dependence. When developing a treatment plan the person's concerns and expectations should be discussed, including: The content on the NICE BNF site (BNF) is the copyright of BMJ Publishing Group Ltd and the Royal Pharmaceutical Society of Great Britain. By using BNF, you agree to the licence set out in the BNF Publications End User Licence Agreement .
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |